Nucleic Acid Testing Market Set to Reach US$ 7.2 Billion by 2033-FMI Study

The nucleic acid testing (NAT) market stands as a revolutionary force in the realm of diagnostics, offering unparalleled insights into genetic information for a wide range of applications. NAT involves the detection and analysis of nucleic acids, such as DNA and RNA, to diagnose diseases, identify pathogens, and assess genetic predispositions. This sophisticated technology has transformed the …